Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference25 articles.
1. Treatment of oncogene-driven non-small cell lung cancer;Kastelijn;Curr Opin Pulm Med,2019
2. Genetic alterations defining NSCLC subtypes and their therapeutic implications;Pikor;Lung Cancer,2013
3. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013
4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N Engl J Med,2014
5. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer;Peters;N Engl J Med,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report;Translational Lung Cancer Research;2023-12
2. Successful Treatment with Crizotinib to Overcome Drug Resistance Possibly Due to <i>Mesenchymal-epithelial Transition</i> Amplification in a Lung Cancer Patient with the <i>Echinoderm Microtubule-associated Protein-like 4-anaplastic Lymphoma Kinase</i> Fusion Gene;Internal Medicine;2023-11-01
3. Treatment of advanced ALK-rearranged NSCLC following second-generation ALK–TKI failure;Expert Review of Anticancer Therapy;2023-10-05
4. The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives;Cancers;2022-09-29
5. MET gene amplification is a mechanism of resistance to entrectinib in ROS1 + NSCLC;Thoracic Cancer;2022-09-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3